Citi analyst David Lebowitz initiated coverage of Viking Therapeutics (VKTX) with a Neutral rating and $38 price target Viking’s VK2735 is an “intriguing potential blockbuster,” with its GLP ...

In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Protagonist Therapeutics (PTGX – Research Report). The company’s shares closed yesterday at ...

DALLAS, Feb. 6, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc., a biotechnology company committed to restoring vision in blind patients in real-world settings by developing and commercializing ...

The three drug discovery deals are with Convelo Therapeutics in neurological disorders such as multiple sclerosis, Sosei Heptares for G-protein-coupled receptor-targeting compounds, and Skyhawk ...

Another company working on an RNA splicing modifier drug for Huntington's is Skyhawk Therapeutics, which reported phase 1 data with its SKY-0515 candidate earlier this year. Earlier this year ...

Roche Holding AG Akt-0.45% CHF234.65B ...

Dyne Therapeutics Inc.-5.60% $1.56B ...

After hours: February 12 at 6:56:56 PM EST Loading Chart for SAGE ...

Discover the Top 20 best Fashion Logos that define style in the industry! From iconic to innovative, explore how these logos captivate audiences! In fashion, logos are more than just symbols; they are ...

Note Includes index. "This book is intended to give the reader an insight into what it was like to be in the close-knit team that was the RNZAF Air Combat Force. Whether in the flying units based at ...